Cyclo-oxygenase-2 (COX-2) inhibition reduces apoptosis in acute myocardial infarction

被引：0
|
作者：
A. Abbate
F. Limana
M. C. Capogrossi
D. Santini
G. G. L. Biondi-Zoccai
S. Scarpa
A. Germani
S. Straino
A. Severino
F. Vasaturo
M. Campioni
G. Liuzzo
F. Crea
G. W. Vetrovec
L. M. Biasucci
A. Baldi
机构：
[1] Virginia Commonwealth University,Department of Medicine
[2] Catholic University,Institute of Cardiology
[3] Istituto Dermopatico Immacolata,Department of Vascular Pathology
[4] Campus Bio-Medico University,Section of Oncology
[5] Università degli Studi “La Sapienza”,Department of Experimental Medicine and of Pathology
[6] Centro Cardiologico Fondazione Monzino,Department of Biochemistry and Biophysics “F. Cedrangolo”, Section of Pathologic Anatomy
[7] Second University of Naples,Department of Medicine
[8] Virginia Commonwealth University,undefined
来源：
Apoptosis | 2006年 / 11卷
关键词：
apoptosis; COX2-inhibitors; cyclo-oxygenase; myocardial infarction; remodelling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1061 / 1063
页数：2
相关论文
共 50 条
  • [41] Clinical Potential of Cyclo-Oxygenase-2 Inhibitors
    Jaime A. Oviedo
    M. Michael Wolfe
    BioDrugs, 2001, 15 : 563 - 572
  • [42] Cyclo-oxygenase-2 inhibitors and cardiovascular events
    Warner, TD
    Mitchell, JA
    Vane, JR
    LANCET, 2002, 360 (9346): : 1700 - 1701
  • [43] STRUCTURE OF THE HUMAN CYCLO-OXYGENASE-2 GENE
    APPLEBY, SB
    RISTIMAKI, A
    NEILSON, K
    NARKO, K
    HLA, T
    BIOCHEMICAL JOURNAL, 1994, 302 : 723 - 727
  • [44] Cyclo-Oxygenase-2 InhibitorsBeneficial or Detrimental for Athletes with Acute Musculoskeletal Injuries?
    Stuart J. Warden
    Sports Medicine, 2005, 35 : 271 - 283
  • [45] Polymorphisms in Two Regions of the Cyclo-Oxygenase-2 Gene Associated with Variation in Risk of Coronary Thrombosis with Cyclo-Oxygenase-2 Inhibitors
    Henry, D.
    Lincz, L.
    Attia, J.
    McElduff, P.
    Bisset, L.
    Peel, R.
    Hancock, S.
    Henderson, K.
    Whitaker, D.
    Seldon, M.
    McGettigan, P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S116 - S116
  • [46] POLYMORPHISMS IN TWO REGIONS OF THE CYCLO-OXYGENASE-2 GENE ASSOCIATED WITH VARIATION IN RISK OF CORONARY THROMBOSIS WITH CYCLO-OXYGENASE-2 INHIBITORS
    Henry, D.
    Lincz, L.
    Attia, J.
    McElduff, P.
    Bisset, L.
    Peel, R.
    Hancock, S.
    Henderson, K.
    Whitaker, D.
    Seldon, M.
    McGettigan, P.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 39 - 39
  • [47] Clinical potential of cyclo-oxygenase-2 inhibitors
    Oviedo, JA
    Wolfe, MM
    BIODRUGS, 2001, 15 (09) : 563 - 572
  • [48] The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene
    McGettigan, Patricia
    Lincz, Lisa F.
    Attia, John
    McElduff, Patrick
    Bissett, Linda
    Peel, Roseanne
    Stokes, Barrie
    Hancock, Stephen
    Henderson, Kim
    Seldon, Michael
    Henry, David
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (04) : 707 - 714
  • [49] Expression of cyclo-oxygenase-2 in ependymal tumors
    Roma, Andres A.
    Prayson, Richard A.
    NEUROPATHOLOGY, 2006, 26 (05) : 422 - 428
  • [50] Increased cyclooxygenase-2 (COX-2) expression in acute myocardial infarction: Therapeutic target of a selective COX-2 inhibitor
    Saito, T
    Rodger, IW
    Hu, F
    Tayara, L
    Giaid, A
    CIRCULATION, 2000, 102 (18) : 271 - 271
12345